Literature DB >> 20811034

Risk evaluation and mitigation strategies: challenges and opportunities for health-system pharmacists.

JoAnn Stubbings1, Rutu A Joshi, James M Hoffman.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20811034     DOI: 10.2146/ajhp090640

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  3 in total

1.  Risk minimization activities of centrally authorized products in the EU: a descriptive study.

Authors:  Inge M Zomerdijk; Fakhredin A Sayed-Tabatabaei; Gianluca Trifirò; Stella C F Blackburn; Miriam C J M Sturkenboom; Sabine M J M Straus
Journal:  Drug Saf       Date:  2012-04-01       Impact factor: 5.606

2.  Usability of FDA-approved medication guides.

Authors:  Michael S Wolf; Jennifer King; Elizabeth A H Wilson; Laura M Curtis; Stacy Cooper Bailey; James Duhig; Allison Russell; Ashley Bergeron; Amanda Daly; Ruth M Parker; Terry C Davis; William H Shrank; Bruce Lambert
Journal:  J Gen Intern Med       Date:  2012-05-08       Impact factor: 5.128

3.  Optimization of REMS Program Compliance in a Large Academic Health System.

Authors:  Audrey B Kostrzewa
Journal:  Innov Pharm       Date:  2021-05-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.